Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

RBC Capital Reaffirms Sector Perform Rating for Thomson Reuters with Price Target of 153

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Finance_Fiscal (3)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 13, 2024, analyst Drew McReynolds from RBC Capital reaffirmed their Sector Perform rating for Thomson Reuters (NYSE: TRI) and kept a price target of $153. This decision was finalized on February 9, 2024, with an increase in the price target from $149 to $153. The adjustment reflects RBC Capital’s positive outlook on Thomson Reuters’ market performance.

Thomson Reuters Corporation (TRI) Stock Price Sees Slight Drop on March 13, 2024

On March 13, 2024, Thomson Reuters Corporation (TRI) experienced a slight decrease in its stock price, closing at $156.70. This represents a 1.16% drop from the previous market close. Despite this decrease, TRI is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum for the stock.

TRI Stock Performance Analysis: Strong Net Income and EPS Growth Despite Flat Revenue

On March 13, 2024, TRI’s stock performance reflected the company’s financial data from the past year. According to CNN Money, TRI reported a total revenue of $6.79 billion for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter was $1.81 billion, also holding flat since the previous quarter. However, despite the stagnant revenue growth, TRI’s net income showed a significant increase. The company reported a net income of $2.69 billion for the past year, marking a 101.42% increase from the previous year. The net income for the fourth quarter was $650 million, holding flat since the previous quarter. Earnings per share (EPS) also saw a notable increase for TRI. The company reported an EPS of $5.80 for the past year, representing a 110.6% increase from the previous year. The EPS for the fourth quarter was $1.49, holding flat since the previous quarter. Overall, TRI’s financial performance on March 13, 2024, demonstrated strong net income and EPS growth, despite flat total revenue. Investors may view the company’s ability to increase profitability as a positive sign for future growth and potential stock performance. It will be interesting to see how TRI continues to navigate the market and maintain its financial momentum in the coming quarters.

Tags: TRI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Cannabis Stock Market Today (1)

Cresco Labs Reports Strong Financial Growth in Q4 2023

Transportation Stock Bull Market

President of Transit at Westinghouse Air Brake Sells 843646 Worth of Company Stock

Anticipating Babcock Wilcoxs Quarterly Earnings A Look at Past Performance and Future Projections

Recommended

Nuscale Power Stock

Nuscale Power Shares Surge on Monumental Nuclear Energy Agreement

2 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago
Finance_ Chart Down

Discover the Top 3 Consumer Stocks with Impressive Dividend Yields Unveiled by Wall Streets Most Accurate Analysts

2 years ago
Eli Lilly Stock

Leadership Shift at Eli Lilly as Neuroscience Head Announces Departure

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Iovance Faces Critical Test as Q3 Earnings Approach

DuPont Faces Critical Test as Quarterly Results Loom

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Trending

Eastman Chemical Stock
Chemicals

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

by Dieter Jaworski
November 6, 2025
0

Eastman Chemical Company finds itself navigating turbulent waters as the global specialty chemicals sector faces significant headwinds....

BioNTech Stock

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

November 6, 2025
Illumina Stock

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

November 6, 2025
Iovance Stock

Iovance Faces Critical Test as Q3 Earnings Approach

November 6, 2025
DuPont de Nemours Stock

DuPont Faces Critical Test as Quarterly Results Loom

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers
  • BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise
  • China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com